Initial report of a single institution experience with teclistamab for relapsed or refractory multiple myeloma including prior BCMA

被引：0
|
作者：
Faiman, Beth [1 ]
Dima, Danai [1 ]
Duco, Marissa [1 ]
Rice, Mikhaila [1 ]
Rudoni, Joslyn [1 ]
Anwer, Faiz [1 ]
Khouri, Jack [1 ]
Mazzoni, Sandra [1 ]
Raza, Shahzad [1 ]
Samaras, Christy [1 ]
Williams, Louis [1 ]
Valent, Jason [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-256
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [1] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Hindie, Elif
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1721 - 1723
  • [2] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Moreau, Philippe
    Garfall, Alfred L.
    van de Donk, Niels W. C. J.
    Nahi, Hareth
    San-Miguel, Jesus F.
    Oriol, Albert
    Nooka, Ajay K.
    Martin, Thomas
    Rosinol, Laura
    Chari, Ajai
    Karlin, Lionel
    Benboubker, Lotfi
    Mateos, Maria-Victoria
    Bahlis, Nizar
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Sidana, Surbhi
    Delforge, Michel
    Pei, Lixia
    Trancucci, Danielle
    Verona, Raluca
    Girgis, Suzette
    Lin, Shun X. W.
    Olyslager, Yunsi
    Jaffe, Mindy
    Uhlar, Clarissa
    Stephenson, Tara
    Van Rampelbergh, Rian
    Banerjee, Arnob
    Goldberg, Jenna D.
    Kobos, Rachel
    Krishnan, Amrita
    Usmani, Saad Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
  • [3] Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Verona, Raluca
    Vieyra, Diego
    Casneuf, Tineke
    Fink, Damien
    Miao, Xin
    Chen, Yang
    Stephenson, Tara
    Banerjee, Arnob
    Hilder, Brandi W.
    Russell, Jeffery
    Infante, Jeffrey
    Elsayed, Yusri
    Smit, Jennifer
    Goldberg, Jenna D.
    BLOOD ADVANCES, 2023, 7 (04) : 644 - 648
  • [4] Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma
    Moore, Donald C.
    Granger, Katelynn
    Hill, Hailey
    Karabinos, Allison
    Davis, James A.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 197 - 200
  • [5] Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed Therapy
    Grajales-Cruz, Ariel F.
    Castaneda, Omar
    Hansen, Doris K.
    Vazquez-Martinez, Mariola A.
    Blue, Brandon
    Khadka, Sushmita
    Liu, Hien
    Ochoa-Bayona, Jose L.
    Freeman, Ciara Louise L.
    Locke, Frederick L.
    Nishihori, Taiga
    Shain, Kenneth
    Baz, Rachid
    Alsina, Melissa
    BLOOD, 2023, 142
  • [6] Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
    Firestone, Ross
    Shekarkhand, Tala
    Patel, Dhwani
    Tan, Carlyn Rose Co
    Hultcrantz, Malin
    Lesokhin, Alexander M.
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Korde, Neha
    Maclachlan, Kylee
    Landau, Heather Jolie
    Scordo, Michael
    Chung, David J.
    Shah, Gunjan L.
    Lahoud, Oscar Boutros
    Giralt, Sergio
    Usmani, Saad Zafar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Brazilian Single-Center Initial Experience and Safety of Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma
    Lopes, Danielle Ovigli
    Kerbauy, Mariana
    Hamerschlak, Nelson
    Helman, Ricardo
    Arcuri, Leonardo
    Kerbauy, Lucila
    Ribeiro, Andreza
    Motta, Mariana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S263 - S263
  • [8] Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
    Lachenal, Florence
    Lebreton, Pierre
    Bouillie, Sylvie
    Matteo, Gian
    Aftisse, Hassina
    Pascal, Laurent
    Montes, Lydia
    Macro, Margaret
    Vignon, Marguerite
    Harel, Stephanie
    Fernandez, Mariana
    Louni, Chanaz
    Huart, Antoine
    Perrot, Aurore
    BLOOD, 2023, 142
  • [9] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
    Cohen, Yael C.
    Magen, Hila
    Gatt, Moshe
    Sebag, Michael
    Kim, Kihyun
    Min, Chang-Ki
    Ocio, Enrique M.
    Yoon, Sung-Soo
    Chu, Michael P.
    Rodriguez-Otero, Paula
    Avivi, Irit
    Quijano Carde, Natalia A.
    Kumar, Ashwini
    Krevvata, Maria
    Peterson, Michelle R.
    Di Scala, Lilla
    Scott, Emma
    Hilder, Brandi
    Vanak, Jill
    Banerjee, Arnob
    Oriol, Albert
    Morillo, Daniel
    Mateos, Maria-Victoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02): : 138 - 149
  • [10] Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naive in Relapsed/Refractory Multiple Myeloma
    Snyder, Jordan
    Graf, Kevin
    Davis, James A.
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Alkharabsheh, Omar
    Hashmi, Hamza
    Shaikh, Hira
    Lochner, Jonathan
    Chang, Darryl
    Atrash, Shebli
    Habib, Alma
    Venkatesh, Priyanka
    Mahmoudjafari, Zahra
    Ahmed, Nausheen
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Green, Kimberly M.
    Khan, Abdullah Mohammad
    BLOOD, 2024, 144 : 24117 - 24118
12345